Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Simcere Pharma

Founders Jinsheng Ren

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$8M
Portfolio companies 5
Rounds per year 0.18
Lead investments 0
Key employees Soon

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Biopharma
  • Health Care
  • Medical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Simcere Pharma:
Typical Co-investors
Simcere Pharma is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Simcere Pharma:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
2U Inc. Hyattsville, Maryland, United States
ANNIVERSAIRE Japan, Tokyo
Growth Street Partners California, San Francisco, United States
JB Partners Colorado, Denver, United States
Mercura Capital Bayern, Germany, Muenchen
Noritsu Precision Japan, Wakayama, Wakayama Prefecture
Qianhai LH Ventures -
Rho Management New York, New York, United States
U2opia Mobile Gurgaon, Haryana, India
VentureHealth California, San Jose, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Cornris Biotech

Biopharma
Medical
Pharmaceutical
11 Dec 2023 Nanjing, Jiangsu, China

Ningdan new drug

Biopharma
Biotechnology
Pharmaceutical
08 Feb 2023 Jiangning, Jiangsu, China

Carmine Therapeutics

Biotechnology
Pharmaceutical
Therapeutics
13 Oct 2022 Cambridge, Massachusetts, United States

Amwise Diagnostic

Biotechnology
Health Care
Life Science
$10M26 Feb 2020 New Taipei, Taiwan

Veritas Genetics

Biotechnology
Genetics
Health Care
Personal Health
$30M17 Oct 2016 Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Simcere Pharma?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 5
Average round size 8M
Rounds per year 0.18
Peak activity year 2023
Lead investments 0
Group Appearance index 0.60

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Cornris Biotech

Biopharma
Medical
Pharmaceutical
11 Dec 2023 Nanjing, Jiangsu, China

Ningdan new drug

Biopharma
Biotechnology
Pharmaceutical
08 Feb 2023 Jiangning, Jiangsu, China

Carmine Therapeutics

Biotechnology
Pharmaceutical
Therapeutics
13 Oct 2022 Cambridge, Massachusetts, United States

Amwise Diagnostic

Biotechnology
Health Care
Life Science
$10M26 Feb 2020 New Taipei, Taiwan

Veritas Genetics

Biotechnology
Genetics
Health Care
Personal Health
$30M17 Oct 2016 Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: